Your browser doesn't support javascript.
loading
SARS-CoV-2 seroprevalence among healthcare personnel at a large health system in Atlanta.
Graciaa, Daniel S; Kempker, Russell R; Wang, Yun F; Schurr, Hanna; Krishnan, Snehaa D; Carroll, Kelley; Toomer, Linda; Merritt, Stephanie; King, Denise; Hunter, Mary; Rebolledo, Paulina A.
Afiliação
  • Graciaa DS; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA. Electronic address: dsgraci@emory.edu.
  • Kempker RR; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
  • Wang YF; Grady Health System, Atlanta, GA, USA; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.
  • Schurr H; Rollins School of Public Health, Emory University, Atlanta, GA, USA.
  • Krishnan SD; Rollins School of Public Health, Emory University, Atlanta, GA, USA.
  • Carroll K; Grady Health System, Atlanta, GA, USA.
  • Toomer L; Grady Health System, Atlanta, GA, USA.
  • Merritt S; Grady Health System, Atlanta, GA, USA.
  • King D; Grady Health System, Atlanta, GA, USA.
  • Hunter M; Grady Health System, Atlanta, GA, USA; Division of General Medicine and Geriatrics, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
  • Rebolledo PA; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA; Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Am J Med Sci ; 364(3): 296-303, 2022 09.
Article em En | MEDLINE | ID: mdl-35430255
BACKGROUND: Estimates of the prevalence of SARS-CoV-2 antibodies and factors associated with infection among healthcare personnel (HCP) vary widely. We conducted a serosurvey of HCP at a large public healthcare system in the Atlanta area. MATERIALS AND METHODS: All employees of Grady Health System were invited to participate in mid-2020; a volunteer sample of those completing testing was included. Asymptomatic HCP were offered testing for IgG antibody and for SARS-CoV-2 RNA using polymerase chain reaction (PCR). Symptomatic HCP were offered PCR testing. Antibody index values for IgG and cycle threshold values for PCR were evaluated for those with a positive result. An online survey was distributed at the time of testing. RESULTS: 624 of 1677 distributed surveys (37.2%) were completed by 608 unique HCP. The majority were female (76.4%) and provided clinical care (70.9%). The most common occupations were clinician (24.8%) and nurse (23.5%). 37 of 608 (6.1%) HCP had detectable IgG. Exposure to a confirmed case of COVID-19 outside of the hospital was associated with detectable IgG (12.8% vs 4.4%, p = 0.02), but exposure to a patient with COVID-19 was not. CONCLUSIONS: Among HCP in a large healthcare system, 6.1% had detectable SARS-CoV-2 IgG. Seropositivity was associated with exposures outside of the healthcare setting.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Am J Med Sci Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Am J Med Sci Ano de publicação: 2022 Tipo de documento: Article